Infection with Acinetobacter baumannii in an intensive care unit in the Western part of Romania

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Lăzureanu, Voichiţa ^a   Poroşnicu, Mirela ^b   Gândac, Ciprian ^b   Moisil, Teodora ^b   Bădiţoiu, Luminiţa ^a   Laza, Ruxandra ^a   Musta, Virgil ^a   Crişan, Alexandru ^a   Marinescu, Adelina Raluca ^b  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Victor Babe Infectious Diseases and Pneumophtisiology Hospital   (Romania)

Author keywords

Acinetobacter baumannii; Antibiotic resistance; Infection; Intensive Care Unit; Mechanical ventilation

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TICARCILLIN; TIMENTIN; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AIRWAY SUCTION DEVICE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOOD CULTURE; CLINICAL ARTICLE; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTRAVENOUS CATHETER; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; PREVALENCE; ROMANIA; TREND STUDY; ACINETOBACTER INFECTIONS; ADULT; CROSS INFECTION; DRUG EFFECTS; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MULTIDRUG RESISTANCE; RETROSPECTIVE STUDY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; ANTI-INFECTIVE AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; RETROSPECTIVE STUDIES; ROMANIA;

EID: 84960108854     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1399-0     Document Type: Article

References (8)

1. World Health Organization: New WHO report shows comparable antibiotic resistance in EU and non-EU countries in the European Region. http://www.euro.who.int/en/health-topics/disease-prevention/antimicrobial-resistance/news/news/2015/11/new-who-report-shows-comparable-antibiotic-resistance-in-eu-and-non-eu-countries-in-the-european-region. Accessed 29 Oct 2015.
2. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. In: CLSI document M100-S9. Wayne, PA: Clinical and Laboratory Standards Institute PA; 2010. p. 54-5.
3. Jehl F, Chomarat M, Weber M, Gerard A. De l àntibiogramme à la prescription. 2ème Edition, BioMérieux 2004.
4. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538-82.
5. Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, et al. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2006;50:2946-50.
6. Streinu-Cercel A. Colistin in the management of severe infections with multidrug resistant Gram-negative bacilli. Germs. 2014;4:7-8.
7. Nica M, Biolan T, Mozeş E, Calistru P, Ceauşu E, Homoş M, et al. Infecţii nosocomiale internate în spitalul clinic de boli infecţioase şi tropicale, Dr.V. Babeş" prin transfer din alte clinici cu profil chirurgical. Rom J Infect Dis. 2007;10:38-45.
8. Siegel JD, Rhinehart E, Jackson M, Chiarello L, the Healthcare Infection Control Practices Advisory Committee: Management of multidrug-resistant organisms in healthcare settings, 2006. In: Centers for Disease Control and Prevention. 2006. http://www.cdc.gov/hicpac/pdf/guidelines/MDROGuideline2006.pdf. Accessed 15 Oct 2015.